cardiovascular constructs with the potential to grow, repair, and remodel represents a promising new concept for cardiac surgery, especially for pediatric patients. Currently, vascular myofibroblast cells (VC) represent an established cell source for cardiovascular tissue engi-neering. Cell isolation requires the invasive harvesting of venous or arterial vessel segments before scaffold seed-ing, a technique that may not be preferable, particularly in pediatric patients. In this study, we investigated the feasibility of using umbilical cord cells (UCC) as an alternative autologous cell source for cardiovascular tis-sue engineering. Methods. Human UCC were isolated from umbilical cord segments and expanded in culture. The cells were sequentia...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
There is increasing scientific evidence that human umbilical cord cells are a valuable source of adu...
Background In vitro fabricated tissue engineered vascular constructs could provide an alternative to...
Objective: A major shortcoming in contemporary congenital heart surgery is the lack of viable replac...
Objective: A major shortcoming in contemporary congenital heart surgery is the lack of viable replac...
The human umbilical cord (UC) has attracted interest as a source of cells for many research applicat...
Over the years, cell therapy has become an exciting opportunity to treat human diseases. Early enthu...
Over the years, cell therapy has become an exciting opportunity to treat human diseases. Early enthu...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
Objective: Tissue engineering of viable, autologous cardiovascular replacements with the potential t...
There is increasing scientific evidence that human umbilical cord cells are a valuable source of adu...
Background In vitro fabricated tissue engineered vascular constructs could provide an alternative to...
Objective: A major shortcoming in contemporary congenital heart surgery is the lack of viable replac...
Objective: A major shortcoming in contemporary congenital heart surgery is the lack of viable replac...
The human umbilical cord (UC) has attracted interest as a source of cells for many research applicat...
Over the years, cell therapy has become an exciting opportunity to treat human diseases. Early enthu...
Over the years, cell therapy has become an exciting opportunity to treat human diseases. Early enthu...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
Presented at: 30. Annual meeting of the German Society for Thoracic and Cardiovascular Surgery in Le...
This study demonstrates the engineering of biologically active heart valve leaflets using prenatally...